Вы находитесь на странице: 1из 18

>

Republic of the Philippines


Department of Health
OFFICE OF THE SECRETARY

__
April 20, 2020
DEPARTMENT MEMORANDUM
No. 2020 - _Q1Q7

TO ALL UNDERSECRETARIES AND ASSISTANT SECRETARIES;


DIRECTORS OF BUREAUS AND CENTERS FOR HEALTH
DEVELOPMENT; MINISTER OF HEALTH BANGSAMORO —~

AUTONOMOUS REGION IN MUSLIM MINDANAO;


EXECUTIVE DIRECTORS OF SPECIALTY HOSPITALS.:
CHIEFS OF MEDICAL CENTERS, HOSPITALS, SANITARIA
AND TREATMENT AND REHABILITATION _CENTERS;
PRESIDENT OF THE PHILIPPINE HEALTH INSURANCE
CORPORATION AND ALL ATTACHED AGENCIES; AND ALL
OTHERS CONCERNED

SUBJECT: Must Know COVID-19 Issuances and Materials as of April 20, 2020

The Department of Health (DOH) and its


line agencies and offices have been proactive in
developing policies that guide government and non-government organizations in the
implementation of various efforts for COVID-19. As new evidence emerges and various
decisions at different levels are made everyday, there is a need to align policy intents and
directions towards ensuring timely, effective and coordinated response to COVID-19.

The ongoing response has been crystallized into a set of guiding principles of COVID-19
response (“Must Know for COVID-19”), which was approved by the DOH Executive
Committee and subsequently adopted by the Inter Agency Task Force on Emerging and
Infectious Diseases. In line with this, all DOH offices and line agencies are directed to:

A. Communication: Use the official terminologies set in the Must Know for COVID-19
Responders document and cascade to
all bureaus, offices, line agencies, centers for health
development, DOH hospitals and specialty centers

B. Intersectoral Coordination: Master the COVID-19 guiding principles and current policy
intents and directions to ensure that these are espoused in all discussions particularly in
national and regional intersectoral meetings.

C. Alignment with DOH policy directions: Ensure strategies, operational policies, actions,
and communications are consistent with DOH policies on COVID-19 of current date: as
TESTING CAPACITY
e AO 2020-0014: Guidelines in Securing a License to Operate a COVID-19 Testing
Laboratory in the Philippines
© DM 2020-0180: Revised Interim Guidelines on Expanded Testing for COVID-19

-
Building 1, San Lazaro Compound, Rizal Avenue, Sta. Cruz, 1003 Manila e Trunk Line 651-7800 local 1108, 1111, 1112, 1113
Direct Line: 711-9502; 711-9503 Fax: 743-1829 @ URL: http://www.doh.gov.ph; e-mail: ftduque@doh.gov.ph
DC 2020-0184: Clarification on Financing & Reimbursement of COVID-19 Antibody
Test Kits by DOH and PhilHealth

MANAGEMENT
AO 2020-0013: Revised AO2020-0012 Guidelines for the Inclusion of COVID-19 in
the List of Notifiable Diseases for Mandatory Reporting to DOH
DM 2020-0138: Adoption of PSMID Clinical Practice Guidelines on COVID-19
DM 2020-0146: Adoption of POGS, PPS, PIDSOG, PSMFM, PSNbM, & PIDSP
Clinical Approach to COVID-19 Mgt. in Pregnancy and Newborn
DM 2020-0176: Interim Guidelines on the Rational Use of Personal Protective
Equipment for COVID-19

HEALTH FACILITIES
e DM 2020-0142: Interim Guidelines on COVID-19 Referral Hospitals

CASE
e DM 2020-0160: Interim Guidelines on Mgt. for NCR Mega Temp. Treatment &
Monitoring Facilities in PICC, WTC, RMC, Ninoy Aquino Stadium & PH Arena
DM 2020-0161: Interim Guidelines on Step Down Care for COVID-19 Response
DM 2020-0162: Interim Guidelines on the Accommodation Arrangement for Health
Workers During COVID-19
e DM 2020-0165: Interim Guidelines for RNDs in Hospitals on Nutritional & Dietary
Mgt. of Suspected, Probable & Confirmed COVID-19 Patients & on the Provision of
Healthy Diet to Hosp. Workforce
e DM 2020-0166: Interim Guidelines on Preparation & Handling of Food in Temporary
Treatment & Monitoring Facilities for COVID-19 Patients
e DM 2020-0167: Interim Guidelines on Proper Handling & Disinfection of Noncritical
Items Used in Mgt. of COVID-19 Patients in All Health Facilities & Temp. Treatment
& Monitoring Facilities
e DM 2020-0168: Interim Guidelines for Dialysis Centers Catering to Suspect,
Probable, & Confirmed COVID-19 Cases
e DM 2020-0170: Interim Guidelines on Mgt. of Healthcare Waste in Health Facilities,
Comm. Quarantine Units & Temp. Treatment & Monitoring Facilities with COVID-19
Cases
e DM 2020-0178: Interim Guidelines on Health Care Provider Networks During the
COVID-19 Pandemic

HEALTH FACILITY NETWORK COMPONENTS


e DM 2020-0133: Request for CHDs to Develop Call Center Coordination Units and
Designate Point Person for Patient and Health Facility Referral esp. in NCR
e DM 2020-0136: Interim Guidelines on Harmonized & Daily Health Facility
Reporting of COVID-19 Related Essential Resources & Supplies Using DOH
DataCollect Application
e MC 2020-0016: DOH-NPC Joint MC2020-0001 Guidelines on the Use of
Telemedicine in COVID-19 Response
e DM 2020-0169: Interim Guidelines on the Grant of Special Authorization to Medical
Graduates to Perform Limited Practice of Medicine by Secretary of Health in
Response to COVID-19

COMMUNITY AND LGU ROLES


e DM 2020-0157: Guidelines on Cleaning & Disinfection in Various Settings as an
Infection Prevention & Control Measure Against COVID-19
e DM 2020-0158: Proper Handling of the Remains of Suspect, Probable & Confirmed
COVID-19 Cases

REPATRIATION
e DM 2020-0181: Revised Interim Guidelines on the Mass Repatriation & Mandatory
Quarantine of Overseas Filipinos Working in Cruise Ships During COVID-19
e DM 2020-0182: Revised Interim Guidelines on the Mass Repatriation & Mandatory
Quarantine of Land-based Overseas Filipinos (OFs) During the COVID-19 Pandemic

PHILHEALTH PACKAGES
e PhilHealth Circular 2020-0009: Benefit Packages for Inpatient Care of Probable &
Confirmed COVID-19 Developing Severe Illness or Outcomes
PhilHealth Circular 2020-0010: Benefit Package for Testing for SARS-CoV-2
PhilHealth Circular 2020-0011: Full Financial Risk Protection for Filipino Health
Workers and Patients Against COVID-19
e PhilHealth Circular 2020-0012: Guidelines on the COVID-19 Community
Isolation Benefit Package (CCIBP)
e PhilHealth Circular 2020-0013: Provisional Accreditation of Health Care
Providers

As science continues to evolve and guide our decision making in


the fight against COVID-19,
we shall regularly update the offices and the Must Know for COVID-19 Responders document.

Should you have queries or concerns, kindly email them to healthypilipinas.doh@gmail.com.


You may also visit http://covid19.healthypilipinas.ph for updated information.

For strict compliance.

matecs T. DUQUE, III, MD, MSc


¥ Secretary of Health
=
References: PSMID Algorithm, DOH Issuances, WHO case classification’
As
of 14 April 2020

I. Case Classification
WITH EXPOSURE
NO EXPOSURE With travel history from a Close contact with a probable
place with local transmission or confirmed case

SUSPECT PROBABLE CONFIRMED


With symptoms Non-COVID (to be tested/awaiting (inconclusive results/ (tested positive)
results) test can't be done)

No symptoms Non-COVID PUM/Contact

II. Patient Pathway

ps Familes and individuals


Nv oil
Telemedicine
L ——= 1

a
NON-COVID-19 PATIENT PATHWAY COVID-19 PATIENT PATHWAY

ce e
G@E2 BHERT
ow

+
v
\ TTMF with Probable, mild
| = .
Primary Care
Facilities/
Primary Care
consults and
A
indivi
ineliie palroams aa
Suspect, mild

Fi Infirmaries services ay LIGTAS


(eg.
COVID-19 Centers)
(eg. RHUs/CHCs/
Private Clinics) Al

al)
=e
EF
TTMF with
sCCohorting
Confirmed, mild

POT im L1-L3
General
Tertiary Care or
hospitalization
(e.g. Mega TTMF;
PICC, etc.)
Bur

=
Hospitals El
(e.g. District
Hospitals) COVID-19 Confirmed, severe

a
Referral Hospital Probable, severe
L Suspect, severe
L
app eaLeals
_— Seer ees} COVID-19 Level 1/ Recovering

roma
Confirmed
|

Hospitals

2 Local transmission: where the source of infection is within the reporting location (WHO, 2020)
MUST KNOW FOR COVID-19 RESPONDERS 2

Temporary Treatment and


Monitoring Facilities (TTMF)?
« TTMFs shall be the general term to be used when referring all isolation/ to

quarantine facilities, set up temporarily to cater to the needs of suspect/


probable/confirmed COVID-19 cases. TTMFs can be further classified into
LIGTAS and MEGA LIGTAS COVID-19 Centers‘.
o LIGTAS COVID-19 CENTER (individual rooms with individual toilets)
primarily caters to Suspect and Probable Cases; can accept Confirmed
Cases if
the facility can do cohorting.

DM
ao MEGA LIGTAS COVID-19 CENTER (cohorting) primarily caters to
Confirmed Cases; can accept Suspect and Probable Cases
individual rooms and toilets.
facility has if
For purposes of
PhilHealth reimbursements: TTMFs and COVID-19 Level 1/Field

DOH
»

hospitals shall be collectively referred to as Community Isolation units (CIUs)°.

3 Per 2020-0123: Interim Guidelines on the Management of Surge Capacity through the Conversion of Public Spaces to Operate as
Temporary Treatment and Monitoring Facilities for the Management of Persons Under Investigation and Mild Cases of Coronavirus Disease 2019
(COVID-19)
4 Official branding of TTMFs
5 Per PhilHealth Circular No. 2020-0012: Community Isolation Units (CIUs) - DOH certified publicly or privately owned non-hospital facilities set-up
in coordination with or by the national government (NG) or local government units (LGUs)
to serve as quarantine facilities for probable and confirmed
cases of COVID-19 based on DOH guidelines.
MUST KNOW FOR COVID-19 RESPONDERS 3


III. Contact Tracing

A. Goals
i. To interrupt ongoing transmission and reduce the spread of infection;
ii, To alert close contacts to the possibility of infection and offer
preventive counselling or care; and
iii, To understand the epidemiology
of
a disease in a particular population

—_
B. Contact Tracing in Different Transmission Scenarios
No Cases Clustered Cases Community
Sporadic Cases roe
Transmission

Implementation Preparation Rigorous Rigorous Continued


of Contact for Contact Contact Contact Contact
Tracing Tracing Tracing Tracing Tracing
+
Assigning of = Conduct = Conduct + Prioritize
contact tracing active case active case contact
teams finding and finding and tracing in
|
*
Preparing listing of close listing ofclose newly/ lesser
We
ele
resources
contacts contacts affected areas
ees
(transportation, Trace, profile, Trace, profile,
7 a

+» =
Prioritize
medical and assess all assess all tracing of
office supplies, close contacts closecontacts high risk close
communication *
Testhighrisk «+
Test high risk contacts
lines, etc.) close contacts closecontacts (high-risk
exposure
contacts,
health
workers)
«
Synergize
with other
measures
such as
physical
distancing

C. Process
i. Contact tracing shall be initiated after case investigation of every
reported confirmed COVID-19 case. list of close contacts shall be
A

developed for every confirmed case and turned over to local contact
tracing teams (LCTT).
ii, LCTTs shall locate, profile and classify close contacts into the following
categories. Testing and quarantine shall depend on the classification
close contacts fall into.
MUST KNOW FOR COVID-19 RESPONDERS 4

CONFIRMED
COVID-19 CASES

Identification and assessment of close contacts

ASYMPTOMATIC

NON-HEALTH HEALTH WORKER HEALTH WORKER


WORKER WITH LOW RISK WITH HIGH RISK
Undergo 14-day strict EXPOSURE EXPOSURE
home quarantine May
report to work but Undergo 14-day strict
shall undergo home quarantine
for
.
Monitor
self-reporting for the
development of end
sign or next 14 days Monitor for development
symptom until of of sign or symptom until
quarantine NOlaboratory end of quarantine
confirmatory testing
NO laboratory Undergo laboratory
confirmatory testing confirmatory testing

DID NOT FIT SUSPECT COVID-19


FIT SUSPECT COVID-19
CASE DEFINITION
CASE DEFINITION

Health facility isolation Undergo 14-day strict home quarantine

Undergo laboratory
Monitor for development of
sign or
symptom until end of quarantine
confirmatory testing
NO
laboratory confirmatory testing

iii, Close contacts undergoing home quarantine shall be monitored by


BHERTs, including any manifestations of signs and symptoms.
MUST KNOW FOR COVID-19 RESPONDERS 5

D. Composition of Local Contact Tracing Teams (LCTT)


i. Team Leader: City or Municipal Health Officer
ii. Co - Team Leader: City or Municipal Philippine National Police Chief
iii. Members: City or Municipal Philippine National Police; physicians,
nurses, midwives, and/or sanitary inspectors from the City or
Municipal Health Office, local population officers, workers and
volunteers from the City or Municipal Population Office, Bureau of Fire
Protection, City or Municipal Disaster Risk Reduction and Management
Office, Barangay Health Emergency Response Team; other staff or
individuals who shall be designated/deputized by the Team Leaders

E. Roles and Responsibilities


AGENCY/
ROLES AND RESPONSIBILITIES
OFFICE
Epidemiology » Provides technical supervision and oversight
Bureau =
Develops guidelines and protocols
» Consolidates and analyzes data on a national scale
DILG » National lead for contact tracing
» Mobilizes contact tracing teams (in line with DOH
guidelines/protocols)
RESU « Informs LESUs of identified suspect, probable, and
confirmed cases
« Orients and capacitate contact tracing teams assigned by
LGUs
» Processes and consolidates reports submitted by PESUs
for submission to DOH-Central Office
PESU » Processes and consolidates reports submitted by C/
MESUs for submission to DOH-Central Office

C/MESU = Conducts case investigation


« Develops list of close contacts
« Conducts specimen collection and transport
» Provides transportation for suspect and probable cases for
referral to health facilities
» Encodes all contact tracing data and other essential
information
Contact Tracing « Traces all close contacts
Team « Provide health education to close contacts
= Collect case and close contact profiles
« Classify close contacts and assess risk level of exposure
BHERT « Serve as navigators of contact tracing teams
« Monitor close contacts under home quarantine
MUST KNOW FOR COVID-19 RESPONDERS 6

F. Information Flow for Contact Tracing

STEP 3

P/C/MESU

STEP 4
LCTT
-
1. Current: Ladderized
i. Notification of confirmed cases from EB > RESU > P/C/MESU
ii, Turnover of close contact list from P/C/MESU > LCTT
iii, Submission of close contact profiles and signs and symptoms
log form
from LCTT > P/C/MESU > RESU > EB

M
9 ~ #< A
=M
ce (> ll
2. Future: Web-based submission and validation
i.
atall
All levels will have access to COVID-19 Info System
levels

ii. Different levels can check and validate data submitted to the system
(similar to Google Drive), based on set of protocols
MUST KNOW FOR COVID-19 RESPONDERS 7

G. Contact Tracing ICT


ti information obtained from epidemiologic investigation and contact
All
tracing shall be submitted via KMITS-registered information systems.
2. DILG, as national lead for contact tracing shall approve contact tracing
applications and technologies. KMITS shall develop standards for the use
of contact tracing applications and technologies, specifying data sharing
protocols/agreements.
Currently, several contact tracing applications and technologies are being
developed, including:
i, COVID KAYA by Dure and WHO
ii, StaySafe.ph
MUST KNOW FOR COVID-19 RESPONDERS 8

IV. Testing
(subject to change once expanded testing capacity has been achieved)

RT-PCR
WITH EXPOSURE
With travel history Close contact with a
EXPOSURE froma place with local probable or confirmed
transmission® case
ae
symptoms
Med Priority y High
9 Priorit ¥ High
g Priorit y

No
ee
Not Priority an
Low Priority eer
Low Priority
symptoms

Prioritization List
Subgroup A: Patients or healthcare workers with severe/eritical
symptoms, relevant history of travel/contact

Subgroup B: Patients or healthcare workers with mild symptoms,


relevant history of travel/contact, and considered
vulnerable
Subgroup C: Patients or healthcare workers with mild symptoms,
relevant history of travel/contact (once with 8000 capacity)

Subgroup D: Patients or healthcare workers with no symptoms but


relevant history of travel/contact (once > 8000 capacity)

Mass Testing (RT-PCR/RATK)


ISSUANCE RT-PCR* RATK

Diagnosis Symptomatic Individuals (Due « Should NOT be used for


to limited capacity and because
viral load of symptomatic patients
diagnosis. Prone
positive results
to false
because
are high enough
accurate)
to
render results because immunity may
result from infection from
Subject to repeat testing if patient anon-COVID virus
tests negative and results worsen « Can be used for subgroup
(less priority compared to those D (least priority for RT-
who have not been tested) PCR
test)
Discharge » No need. Test to follow + No need. Test to follow
Determination «=
No need - Can be used to
of full
recovery determine full recovery
if asymptomatic patient
tests positive for IgG
(regardless of IgM result)
*All RT-PCR tests regardless of result should undergo 14-day isolation upon testing

6 Local transmission: where the source of infection is within the reporting location (WHO, 2020)
MUST KNOW FOR COVID-19 RESPONDERS 9

RT-PCR (Reverse-Transcription Polymerase Chain Reaction)


a. Best to be administered to symptomatic individuals because their
viral load is high enough tostill
render the test accurate (but even with
enough viral load, tests are subject to a level of inaccuracy)
b. Patients who tested negative, but their symptoms worsened should
be tested again
c. 14-day isolation needed every time test is administered regardless of
test results

RATK (Rapid Antibody-based Test Kits)


a. Recommended to NOT be used as
a confirmatory test. Being IgG
positive is prone to
false positive results because immunity may have
been developed due to
another infection (non-COVID)
b. Recommended that the RATK
test ensure
to that the
is
used after a confirmatory RT-PCR
immunity developed was due to COVID-19.,
But due limitedtoRT-PCR
to be done ona large scale
testing capacity, this is not recommended
c. Expanded use of RATKs are recommended to Subgroup
testing priority)
(lowest D
V. Case Management (Isolation / Quarantine)
WITH EXPOSURE
NO EXPOSURE Close contact with a probable
With travel history
or confirmed case

Isolation: Needs medical attention/symptom management


Witivsyimpiomis “Usuali@ste
and monitoring by a medical personnel

Quarantine: Needs monitoring to take action as needed


(1)
No symptoms N/A for possible onset symptoms, and (2) ensure restricted
of
movement by a non-medical personnel of the BHERT

Technical Recommendation
Adopt a clear delineation between isolation and quarantine’ terminologies
primarily to support the rationalizing of medical attention for monitoring of
patients.

7 https://www.cde,.gov/quarantine/index.htm! (a) Isolation separates sick people with a contagious disease from people who arenot sick. (b)
Quarantine separates and restricts the movement of people who were exposed to to if
a contagious disease see they become sick.
MUST KNOW FOR COVID-19 RESPONDERS 10

VI. Patient Navigation


1st Option 2nd Option 3rd Option
With CONFIRMED (POSITIVE TEST)
Symptoms ild TTMF with cohorting Home-based COVID-19 Level
self-isolation 1/field hospitals
(Mega LIGTAS COVID
Centers
or LIGTAS COVID
Centers with Cohorting)
Severe COVID-19 referral - -
hospitals
Recovering Home-based
COVID-19 Level 1/field -
hospitals self-isolation
PROBABLE (INCONCLUSIVE RESULTS OR CAN'T BE TESTED)
Mild TTMF individual rooms Home-based COVID-19 Level
and individual toilets self-isolation 1/field hospitals

(LIGTAS COVID-19
Center or Mega LIGTAS
COVID CENTER
individual rooms and
toilets)
Severe COVID-19 referral - -
hospitals
SUSPECT (FOR TESTING OR AWAITING RESULTS)
Mild TTMF with individual Home-based COVID-19 Level
rooms and individual self-isolation 1/field hospitals
toilets

(LIGTAS COVID-19
Center or Mega LIGTAS
COVID CENTER with
individual rooms and
individual toilets)
Severe COVID-19 referral General and -
hospitals Specialty
Hospitals (Level
2,3)
No Possible TTMEF
with individual Home-based -
symptoms Case/ rooms and individual quarantine
Contact toilets

(LIGTAS COVID-19
Center)
MUST KNOW FOR COVID-19 RESPONDERS 1

Facility-based quarantine and isolation shall be the first option.


«
Temporary Treatment and Monitoring Facilities
o LIGTAS COVID-19 CENTER primarily caters to Suspect and

Probable Cases; can accept Confirmed Cases


cohorting.
if
the facility can do

9 MEGA LIGTAS COVID-19 CENTER primarily caters to Confirmed


Cases; can accept Suspect and Probable Cases
individual rooms and individual toilets.
if
facility has

* COVID-19 Level 1/Field Hospitals primarily caters to Recovering Confirmed


Case that has been cleared for step-down care.

Home-based quarantine and


are compliant with the checklist.
isolation can be done
if house facilities/conditions
Case Classification
» Probable Cases with severe symptoms shall be clinically treated/managed
as a confirmed case.
»
Suspect/Probable/Confirmed shall be used for reporting purposes.
« Possible/contact will still be monitored receiving appropriate interventions
but will no longer be reported.

Financing RATK
» In compliance with RA11223, DOH and PhilHealth remain precluded in
financing and reimbursing Rapid Antibody test kits respectively since
not yet positively recommended by the HTA Council (HTAC). At present,
is
it
HTAC only recommends the use of RATK as part of a parallel multi-site
clinical trial and not as a sole screening and diagnostic tool for COVID-19

»
due
to limited evidence of
its accuracy or benefit (or absence of harm).
However, other public or private institutions are not prohibited from
purchasing and using RATK as long as FDA and DOH guidelines on its
purchase and use are followed.
MUST KNOW FOR COVID-19 RESPONDERS 12

VII. Patient Recovery


« Confirmed/Probable/Suspect Cases
Recovering Clinically-resolved Fully Recovered For reintegration to
symptoms the community
Can be referred to Can be discharged/ Completed 14-day Secured a certification
a lower level facility sent home upon facility/home based from the CHD-RESU
upon clearance by the clearance by the isolation and, if testing facilitated by the
attending physician. attending physician. capacity allows, has BHERT
tested negative for
RT-PCR®

« Current policy: no need to test negative for RT-PCR prior to discharge


» RT-PCR
virus.
is
not the recognized gold standard to determine recovery from the

VIII. Handling of Remains


For all suspect, probable, and confirmed cases

Tagging of For referral facility/ Attending physician/ duly authorized personnel to


cadaver hospital deaths tag cadaver
For deaths outside of Local Health Office to tag cadaver
referral facility/hospital
Designation of All LGUs to designate through MOA
funeral service
providers/
crematorium
Charging of 1. Surviving spouse 3. LGU of residence of deceased or next of kin
expenses for 2. Nearest kin 4, LGU where patient
expired
funeral services
(in order or *if indigent or kin is classified as vulnerable, disadvantaged, or in crisis
priority) situation, LGU shall shoulder expenses and DSWD to
defray excess costs
Transport for If with living spouse/ Spouse/next kin of
to coordinate with funeral service
burial next of kin provider to
transport from hospital to burial site/
crematorium
If unclaimed LGU
to
secure transportation, retrieval, and transfer
to funeral service provider
For Claimed Upon the discretion of the spouse
or
next of kin
whether the remains are buried or cremated, No
public viewing of the deceased shall be allowed.
For Unclaimed Method of
disposal by priority:
1, Cremation
2. Double-sealed casket burial
3. Double bag burial
4, Freezer (for temporary storage)
For those with Islamic Procedure:
Faith 1, Hygiene preparations of body (e.g. cleaning
of body, trimming, shaving, embalming) shall
not be allowed
2. Wrap in
for burial
tightly sealed cloth with double bag

8 Evolving discussion: use of Rapid testing as an alternative to the RT-PCR


=
MUST KNOW FOR COVID-19 RESPONDERS 13

IX. Financing COVID-19 Response


***Charging & billing of patients using donated PPEs are prohibited

PHILHealth PACKAGE
EXPENDITURE FACILITY NG/LGU
AMOUNT

COVID-19 Testing center Technical Only protocol-based testing


Testing support (following prioritization) will
Test kits be covered by PhilHealth.
CAPEX If testing was not paid for
PPE by DOH
and test kit
the
HRH used was not donated:
Php 8,150.00/test
If testing was not paid for
by DOH but the test kit
used was donated:
Php 5,450.00/test
If testing was paid for by
DOH
and the test kit used
was donated:
Php 2,710.00/test
Community- ClUs Technical Php 22,449.00/isolation
based support cycle (min 14 days, unless
management CAPEX otherwise indicated*)
PPE
HRH
Hospital-based COVID-19 Level Technical Ifwith mild pneumonia
management 1/field hospital support in elderly or with
CAPEX co-morbidities:
PPE Php 43,997.00
COVID-19 HRH If with moderate
referral hospital pneumonia:
Php 143,267.00
If with severe pneumonia:

Php 335,519.00
If with critical pneumonia:

Php 786,384.00
MUST KNOW FOR COVID-19 RESPONDERS 14

X. Ensuring Data Privacy in Reporting of Personal Information


A. Pursuant to Republic Act 101 Data Privacy Act of 2012, declaration form shall be
given to and signed by COVID-19 patients and close contacts, or their relatives,
caregivers, and/or guardians, prior to conducting epidemiologic investigation
or close contact interviews. A privacy notice shall be provided to inform
patients and contacts on the processing of information.

All identified close contacts shall be assigned anonymised identification for the
purpose of information sharing to or data analysis by individuals other than the
personal information controller or those designated to have access
and sensitive information.
to personal

Names and other unique identifiers shall NOT be released publicly or shared
with entities not directly involved in the care of the patient, or entities
unauthorized by law or other legal instruments to process such information,
without the patient's consent. Violations of this provision shall be punishable
by the penalties set by RA10173.

Only information relevant to the contact tracing shall be collected. The DOH
reserves the right to release information on COVID-19 patients that are relevant
for public health interventions without full disclosure of the patient's identity.

The with other government agencies involved and/or contributing to the


DOH

contact tracing shall form a memorandum of agreement on data sharing to


ensure proper use and accountability of personal information being collected.

The Epidemiology Bureau shall be the personal information controller who will
be responsible for directing all actions related to the data, including the use of
personal information needed for the conduct of COVID-19 response activities
such as contact tracing.

The RESU, the LESU, other surveillance units and deputized agencies shall be
personal information processors and shall be responsible for assigning a data
protection officer and data protection controls such as privacy and breach
management.
MUST KNOW FOR COVID-19 RESPONDERS 15

XI. Accountability Lines for COVID-19 Response


National government-enabled, LGU-led, patient-centered COVID-19 response

GUIDING PRINCIPLES
1.
for “new normal”
Whole-of-government, whole-of-system, whole-of society shall
approach
be espoused in
the fight against COVID-19;
2. Science shall inform decision-making at the institutional and individual
level;
3, Recognizing limited resources, response shall be guided by fair and
transparent priority setting;
4. In the event of any conflict of rules or guidelines, human dignity and the
safety and needs of
the individual shall prevail.

National government
National government
(implementation and Local government
(policy and strategy)
coordination)
Lead Interagency Task Force National Task Force Local government
through NGAs through Task Groups units
Main « Strategies « Enforcement of +
Implementation
accountabilities + Guidelines strategies « Service delivery
+ Standards + Roll out plans
Impact monitoring « Resource mobilization
«
Operations monitoring

This document shall be updated regularly as science continues to evolve and guide our decision
making
in the fight against COVID-19.

Should you have queries or concerns, kindly email them to healthypilipinas.doh@gmail.com. You
may also visit http://covid19.healthypilipinas.ph for updated information.